Docking of cationic antibiotics to negatively charged pockets in RNA folds

Journal of Medicinal Chemistry

Volumn 42, Issue 7, 1999, Pages 1250-1261

  Hermann, Thomas ^a   Westhof, Eric ^a  

^a INST DE BIOL MOLEC ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; KANAMYCIN; NEOMYCIN; PAROMOMYCIN; RIBOSOME RNA; RNA; TOBRAMYCIN;

ARTICLE; BINDING SITE; DIFFUSION; DRUG BINDING; ELECTRICITY; MOLECULAR DYNAMICS; SIMULATION;

ANTI-BACTERIAL AGENTS; BINDING SITES; HIV-1; KANAMYCIN; MODELS, MOLECULAR; NEOMYCIN; PROTEIN CONFORMATION; RESPONSE ELEMENTS; RNA; RNA, RIBOSOMAL, 16S; TOBRAMYCIN;

EID: 0033535566     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm981108g     Document Type: Article

References (82)

1. Wang, Y.; Rando, R. R. Specific binding of aminoglycoside antibiotics to RNA. Chem. Biol. 1995, 2, 281-290.
2. Moazed, S.; Noller, H. F. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 1987, 327, 389-394.
3. Mei, H.-Y.; Galan, A. A.; Halim, N. S.; Mack, D. P.; Moreland, D. W.; Sanders, K. B.; Truong, H. N.; Czarnik, A. W. Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics. Bioorg. Med. Chem. Lett. 1995, 5, 2755-2760.
4. Pearson, N. D.; Prescott, C. D. RNA as a drug target. Chem. Biol. 1997, 4, 409-414.
5. Chow, C. S.; Bogdan, F. M. A structural basis for RNA-ligand interactions. Chem. Rev. 1997, 97, 1489-1513.
6. Hermann, T.; Westhof, E. RNA as a drug target: chemical, modelling, and evolutionary tools. Curr. Opin. Biotechnol. 1998, 9, 66-73.
7. Burgstaller, P.; Hermann, T.; Huber, C.; Westhof, E.; Famulok, M. Isoalloxazine derivatives promote photocleavage of natural RNAs at G-U base pairs embedded within helices. Nucleic Acids Res. 1997, 25, 4018-4027.
8. Wang, H.; Tor, Y. Electrostatic interactions in RNA aminoglycosides binding. J. Am. Chem. Soc. 1997, 119, 8734-8735.
9. Li, K.; Fernandez-Saiz, M.; Rigl, C. T.; Kumar, A.; Ragunathan, K. G.; McConnaughie, A. W.; Boykin, D. W.; Schneider, H. J.; Wilson, W. D. Design and analysis of molecular motifs for specific recognition of RNA. Bioorg. Med. Chem. 1997, 5, 1157-1172
10. Hermann, T.; Westhof, E. Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA. J. Mol. Biol. 1998, 276, 903-912.
11. Hamy, F.; Brondani, V.; Flörsheimer, A.; Stark, W.; Blommers, M. J. J.; Klimkait, T. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition. Biochemistry 1998, 37, 5086-5095.
12. Tor, Y.; Hermann, T.; Westhof, E. Deciphering RNA Recognition: Aminoglycoside binding to the hammerhead ribozyme. Chem. Biol. 1998, 5, R277-R283.
13. Wilson, W. D.; Ratmeyer, L.; Zhao, M.; Strekowski, L.; Boykin, D. The search for structure-specific nucleic acid-interactive drugs: effects of compound structure on RNA versus DNA interaction strength. Biochemistry 1993, 32, 4098-4104.
14. Fernandez-Saiz, M.; Schneider, H. J.; Sartorius, J.; Wilson, W. D. A cationic cyclophane that forms a base-pair open complex with RNA duplexes. J. Am. Chem. Soc. 1996, 118, 4739-4745.
15. Wilson, W. D.; Ratmeyer, L.; Zhao, M.; Ding, D.; McConnaughie, A. W.; Kumar, A.; Boykin, D. W. Design and analysis of RNA structure-specific agents a potential antivirals. J. Mol. Recog. 1996, 9, 187-196.
16. Schroeder, R.; von Ahsen, U. Interaction of aminoglycoside antibiotics with RNA. Nucleic Acids Mol. Biol. 1996, 10, 53-74.
17. Noller, H. F. Ribosomal RNA and translation. Annu. Rev. Biochem. 1991, 60, 191-227.
18. Fourmy, D.; Recht, M. I.; Blanchard, S. C.; Puglisi, J. D. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 1996, 274, 1367-1371.
19. Zapp, M. L.; Stern, S.; Green, M. R. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 1993, 74, 969-978.
20. Mei, H.-Y.; Mack, D. P.; Galan, A. A.; Halim, N. S.; Heldsinger, A.; Loo, J. A.; Moreland, D. W.; Sannes-Lowery, K. A.; Sharmeen, L.; Truong, H. N.; Czarnik, A. W. Discovery of selective small-molecule inhibitors of RNA complexes: the Tat protein/TAR RNA complexes required for HIV-1 transciption. Bioorg. Med. Chem. 1997, 5, 1173-1184.
21. von Ahsen, U.; Davies, J.; Schroeder, R. Antibiotic inhibition of group I ribozyme function. Nature 1991, 353, 368-370.
22. Rogers, J.; Chang, A. H.; von Ahsen, U.; Schroeder, R.; Davies, J. Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. J. Mol. Biol. 1996, 259, 916-925.
23. Stage, T. K.; Hertel, K. J.; Uhlenbeck, O. C. Inhibition of the hammerhead ribozyme by neomycin. RNA 1995, 1, 95-101.
24. Clouet-d'Orval, B.; Stage, T. K.; Uhlenbeck, O. C. Neomycin inhibition of the hammerhead ribozyme involves ionic interactions. Biochemistry 1995, 34, 11186-11190.
25. Botto, R. E.; Coxon, B. Nitrogen-15 nuclear magnetic resonance spectroscopy of neomycin B and related aminoglycosides. J. Am. Chem. Soc. 1983, 105, 1021-1028.
26. Dahm, S. C.; Uhlenbeck, O. C. Role of divalent metal ions in the hammerhead RNA cleavage reaction. Biochemistry 1991, 30, 9464-9469.
27. Long, D. M.; LaRiviere, F. J.; Uhlenbeck, O. C. Divalent metal ions and the internal equilibrium of the hammerhead ribozyme. Biochemistry 1995, 34, 14435-14440.
28. Jack, A.; Ladner, J. E.; Rhodes, D.; Brown, R. S.; Klug, A. A crystallographic study of metal-binding to yeast phenylalanine transfer RNA. J. Mol. Biol. 1977, 111, 315-328.
29. Pley, H. W.; Flaherty, K. M.; McKay, D. B. Three-dimensional structure of a hammerhead ribozyme. Nature 1994, 372, 68-74.
30. Scott, W. G.; Murray, J. B.; Arnold, J. R. P.; Stoddard, B. L.; Klug, A. Capturing the structure of a catalytic RNA intermediate: the hammerhead ribozyme. Science 1996, 274, 2065-2069.
31. Cate, J. H.; Doudna, J. A. Metal-binding sites in the major groove of a large ribozyme domain. Structure 1996, 4, 1221-1229.
32. Correll, C. C.; Freeborn, B.; Moore, P. B.; Steitz, T. A. Metals, motifs, and recognition in the crystal structure of a 5S rRNA domain. Cell 1997, 91, 705-712.
33. Teeter, M. M.; Quigley, G. J.; Rich, A. Metal ions and transfer RNA. In Nucleic acid-metal ion interactions; Spiro, T. G., Ed.; Wiley: New York, 1980; pp 145-177.
34. Pan, T.; Long, D. M.; Uhlenbeck, O. C. Divalent metal ions in RNA folding and catalysis. In The RNA world; Gesteland, R. F., Atkins, J. F., Eds.; Cold Spring Harbor Laboratory Press: New York, 1993; pp 271-302.
35. Phe - implications for lead toxicity and self-splicing RNA. Nature 1983, 303, 543-546.
36. Phe by specific metal ion-induced cleavages. FEBS Lett. 1989, 243, 293-298.
37. Streicher, B.; von Ahsen, U.; Schroeder, R. Lead cleavage sites in the core structure of group I intron-RNA. Nucleic Acids Res. 1993, 21, 311-317.
38. Berens, C.; Streicher, B.; Schroeder, R.; Hillen, W. Visualizing metal-ion-binding sites in group I introns by iron(II)-mediated Fenton reactions. Chem. Biol. 1998, 5, 163-175.
39. Eckstein, F.; Gish, G. Phosphorothioates in molecular biology. Trends Biochem. Sci. 1989, 14, 97-100.
40. fMet. Biochemistry 1976, 15, 157-160.
41. Guéron, M.; Leroy, J. L. Significance and mechanism of divalention binding to transfer RNA. Biophys. J. 1982, 38, 231-236.
42. Phe. Nucleic Acids Res. 1977, 4, 2811-2820.
43. Westhof, E.; Dumas, P.; Moras, D. Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RNA crystals. Acta Crystallogr. A 1988, 44, 112-123.
44. Hermann, T.; Westhof, E. Exploration of metal ion binding sites in RNA folds with Brownian dynamics simulations. Structure 1998, 6, 1303-1314.
45. Madura, J. D.; Davis, M. E.; Gilson, M. K.; Wade, R. C.; Luty, B. A.; McCammon, J. A. Biological applications of electrostatic calculations and Brownian dynamics simulations. Rev. Comput. Chem. 1994, 5, 229-267.
46. Jiang, L.; Suri, A. K.; Fiala, R.; Patel, D. J. Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex. Chem. Biol. 1996, 4, 35-50.
47. Jiang, L.; Patel, D. J. Solution structure of the tobramycin-RNA aptamer complex. Nature Struct. Biol. 1998, 5, 769-774.
48. Purohit, P.; Stern, S. Interactions of a small RNA with antibioticand RNA ligands of the 30S subunit. Nature 1994, 370, 659-662.
49. Miyaguchi, H.; Narita, H.; Sakamoto, K.; Yokoyama, S. An antibiotic-binding motif of an RNA fragment derived from the A-site-related region of Escherichia coli 16S rRNA. Nucleic Acids Res. 1996, 24, 3700-3706.
50. Fourmy, D.; Recht, M. I.; Puglisi, J. D. Binding of neomycinclass aminoglycoside antibiotics to the A-site of 16 S rRNA. J. Mol. Biol. 1998, 277, 347-362.
51. Wang, S.; Huber, P. W.; Cui, M.; Czarnik, A. W.; Mei, H.-Y. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry 1998, 37, 5549-5557.
52. Mei, H.-Y.; Cui, M.; Heldsinger, A.; Lamrow, S. M.; Loo, J. A.; Sannes-Lowery, K. A.; Sharmeen, L.; Czarnik, A. W. Inhibitors of protein-RNA complexation that target RNA: specific recognition of HIV-1 TAR RNA by small organic molecules. Biochemistry 1998, 37, 14204-14212.
53. Patel, D. J.; Suri, A. K.; Jiang, F.; Jiang, L.; Fan, P.; Kumar, R. A.; Nonin, S. Structure, recognition and adaptive binding in RNA aptamer complexes. J. Mol. Biol. 1997, 272, 645-664.
54. Wallis, M. G.; von Ahsen, U.; Schroeder, R.; Famulok, M. A novel RNA motif for neomycin recognition. Chem. Biol. 1995, 2, 543-552.
55. Lato, S. M.; Boles, A. R.; Ellington, A. D. In vitro selection of RNA lectins: using combinatorial chemistry to interpret ribozyme evolution. Chem. Biol. 1995, 2, 291-303.
56. Famulok, M.; Hüttenhofer, A. In vitro selection analysis of neomycin binding RNAs with a mutagenized pool of variants of the 16S rRNA decoding region. Biochemistry 1996, 35, 4265-4270.
57. Wallace, S. T.; Schroeder, R. In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination between antibiotics. RNA 1998, 4, 112-123.
58. Recht, M. I.; Fourmy, D.; Blanchard, S. C.; Dahlquist, K. D.; Puglisi, J. D. RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide. J. Mol. Biol. 1996, 262, 421-436.
59. Spickler, C.; Brunelle, M.-N.; Brakier-Gingras, L. Streptomycin binds to the decoding center of 16 S ribosomal RNA. J. Mol. Biol. 1997, 273, 586-599.
60. Blanchard, S. C.; Fourmy, D.; Eason, R. G.; Puglisi, J. D. rRNA chemical groups required for aminoglycoside binding. Biochemistry 1998, 37, 7716-7724.
61. Wong, C.-H.; Hendrix, M.; Priestley, E. S.; Greenberg, W. A. Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA. Chem. Biol. 1998, 5, 397-406.
62. Fourmy, D.; Yoshozawa, S.; Puglisi, J. D. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J. Mol. Biol. 1998, 277, 333-345.
63. Beneviste, R.; Davies, J. Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups. Antimicrob. Agents Chemother. 1973, 4, 402-409.
64. Alper, P. B.; Hendrix, M.; Sears, P.; Wong, C.-H. Probing the specificity of aminoglycoside ribosomal RNA interactions with designed synthetic analogues. J. Am. Chem. Soc. 1998, 120, 1965-1978.
65. Wang, Y.; Kilian, J.; Hamasaki, K.; Rando, R. R. RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities. Biochemistry 1996, 35, 12338-12346.
66. Wang, Y.; Hamasaki, K.; Rando, R. R. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region. Biochemistry 1997, 36, 768-779.
67. Hamasaki, K.; Kilian, J.; Cho, J.; Rando, R. R. Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities. Biochemistry 1998, 37, 656-663.
68. Frankel, A. D.; Young, J. A. T. HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 1998, 67, 1-25.
69. Aboul-ela, F.; Karn, J.; Varani, G. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 1995, 253, 313-332.
70. Aboul-ela, F.; Karn, J.; Varani, G. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res. 1996, 24, 3974-3981.
71. Ye, X.; Kumar, R. A.; Patel, D. J. Molecular recognition in the bovine immunodeficiency virus TAT peptide-TAR RNA complex. Chem. Biol. 1995, 2, 827-840.
72. Puglisi, J. D.; Chen, L.; Blanchard, S.; Frankel, A. D. Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex. Science 1995, 270, 1200-1203.
73. Hamy, F.; Felder, E. R.; Heizmann, G.; Lazdins, J.; Aboul-Ela, F.; Varani, G.; Karn, J.; Klimkait, T. An inhibitor of the Tat/ TAR RNA interaction that effectively suppresses HIV-1 replication. Proc. Natl Acad. Sci. U.S.A. 1997, 94, 3548-3553.
74. Leclerc, F.; Cedergren, R. Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex. J. Med. Chem. 1998, 41, 175-182.
75. Pritchard, C. E.; Grasby, J. A.; Hamy, F.; Zacharech, A. M.; Singh, M.; Karn, J.; Gait, M. J. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus Tat and rev proteins. Nucleic Acids Res. 1994, 22, 2592-2600.
76. Hamy, F.; Asseline, V.; Grasby, J.; Iwai, S.; Pritchard, C.; Slim, G.; Butler, P. J. G.; Karn, J.; Gait, M. Hydrogen bonding contacts in the major groove are required for human immunodeficieny virus type-1 Tat protein recognition of TAR RNA. J. Mol. Biol. 1993, 230, 111-123.
77. Huq, I.; Rana, T. M. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving. Biochemistry 1997, 36, 12592-12599.
78. Wang, W.; Rana, T. M. RNA-protein interactions in the Tat-trans-activation response element complex determined by site-specific photo-cross-linking. Biochemistry 1998, 37, 4235-4243.
79. Dinur, U.; Hagler, A. T. New approaches to empirical force fields. Rev. Comput. Chem. 1991, 2, 99-164.
80. Gundertofte, K.; Liljefors, T.; Norrby, P. O. A comparison of conformational energies calculated by several molecular mechanics methods. J. Comput. Chem. 1996, 17, 429-449.
81. Nicholls, A.; Sharp, K. A.; Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991, 11, 281-296.
82. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A second generation force field for the simulation of proteins, nucleic acids and organic molecules. J. Am. Chem. Soc. 1995, 117, 5179-5197.